AnzaloneAV, KoblanLW, LiuDR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol, 2020; 38:824–844. DOI: 10.1038/s41587-020-0561-9.
2.
MakarovaKS, WolfYI, IranzoJ, et al.Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol, 2020; 18:67–83. DOI: 10.1038/s41579-019-0299-x.
3.
ZetscheB, GootenbergJS, AbudayyehOO, et al.Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 2015; 163:759–771. DOI: 10.1016/j.cell.2015.09.038.
4.
ShmakovS, AbudayyehOO, MakarovaKS, et al.Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol Cell, 2015; 60:385–397. DOI: 10.1016/j.molcel.2015.10.008.
5.
JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337:816–821. DOI: 10.1126/science.1225829.
6.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339:819–823. DOI: 10.1126/science.1231143.
7.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339:823–826. DOI: 10.1126/science.1232033.
KundertK, LucasJE, WattersKE, et al.Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs. Nat Commun, 2019; 10:2127. DOI: 10.1038/s41467-019-09985-2.
12.
DahlmanJE, AbudayyehOO, JoungJ, et al.Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat Biotechnol, 2015; 33:1159–1161. DOI: 10.1038/nbt.3390.
13.
ShenMW, ArbabM, HsuJY, et al.Predictable and precise template-free CRISPR editing of pathogenic variants. Nature, 2018; 563:646–651. DOI: 10.1038/s41586-018-0686-x.
14.
JoungJ, LadhaA, SaitoM, et al.Detection of SARS-CoV-2 with SHERLOCK one-pot testing. New Engl J Med, 2020; 383:1492–1494. DOI: 10.1056/NEJMc2026172.
